• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Koninklijke Philips (ENXTAM:PHIA) Expands Virtual Monitoring, Is The Stock Fully Priced?

    Simply Wall St·07/27/2026 07:23:50
    Listen to the news

    Koninklijke Philips (ENXTAM:PHIA) is in focus after West Tennessee Healthcare selected Philips and hellocare.ai to deploy virtual monitoring across 127 ICU beds and 17 emergency department carts, integrating with Philips’ connected care capabilities.

    See our latest analysis for Koninklijke Philips.

    The latest virtual monitoring rollout sits against a relatively steady share price backdrop, with Koninklijke Philips’ €23.16 stock showing muted short term moves while a 1 year total shareholder return of 8.79% suggests more support over a longer horizon.

    If this kind of connected care story interests you, it could be worth seeing what else is emerging in healthcare related AI by scanning our 129 healthcare AI stocks

    After a steady year and a relatively muted recent move, the real tension around Koninklijke Philips is whether this connected care push means there is still meaningful upside to price in, or if most of the rerating is already behind the stock.

    Most Popular Narrative: 17.1% Undervalued

    Against the last close of €23.16 for Koninklijke Philips, the most followed narrative points to a fair value of about €27.93, framing the current connected care news inside a wider earnings and cash flow story.

    Analysts are assuming Koninklijke Philips's revenue will grow by 4.0% annually over the next 3 years. Analysts assume that profit margins will increase from 5.5% today to 8.2% in 3 years time.

    Read the complete narrative.

    Want to see what sits behind that valuation gap? The story focuses on steadier revenue growth, firmer margins and a future earnings multiple that has to do a lot of work.

    Result: Fair Value of €27.93 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, the Koninklijke Philips story could be knocked off course if tariff pressures increase costs or if extended regulatory scrutiny keeps legal and remediation spending elevated.

    Find out about the key risks to this Koninklijke Philips narrative.

    Another View: What Multiples Say About Koninklijke Philips

    While the most popular narrative frames Koninklijke Philips as 17.1% undervalued on fair value estimates, the current P/E of 23.2x looks a bit richer than peer averages at 21.3x, even though it sits below the broader European Medical Equipment group at 26x. That mix of relative value and premium to peers raises a simple question for you: is the extra price tag justified by your conviction in the earnings story?

    See what the numbers say about this price — find out in our valuation breakdown.

    ENXTAM:PHIA P/E Ratio as at Jul 2026
    ENXTAM:PHIA P/E Ratio as at Jul 2026

    Next Steps

    Mixed messages in the Koninklijke Philips story so far? Take a closer look at the numbers, weigh both the concerns and the optimistic signals, and then review the 4 key rewards and 3 important warning signs

    Looking for more investment ideas beyond Koninklijke Philips?

    If you are serious about building a stronger portfolio, do not stop with Koninklijke Philips, use the Simply Wall St Screener today or risk missing fresh opportunities.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.